Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Genprex Shares Soar 250% on FDA Fast Track Designation for Lung Cancer Drug

Genprex's shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib. This morning, Genprex Inc. (GNPX:NASDAQ) , which "utilizes a...
Streetwise Reports | January 22, 2020 |

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

Ontario Mine On Track for First Gold Pour in Late 2020

The latest news and a construction update on Pure Gold Mining's Canadian project are provided in an Echelon Wealth Partners report. In a March 30 research note, Echelon Wealth Partners analyst Ryan Walker reported that Pure Gold Mining Inc. (PGM:TSX.V; PUR:LSE) r...
Streetwise Reports | April 8, 2020 |

With Its Val d'Or Assets, Exploration Company 'On Track to Get Serious Attention'

The recently released resource estimate and other reasons why this Canadian firm makes a premium takeout target are provided in an iA Securities report. In a Sept. 3 research note, iA Securities analyst George Topping reported that the size, potential and location of ...
Streetwise Reports | September 9, 2019 |

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports | January 16, 2020 |

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. In a news release , Draganfly Inc. (DFLY:CSE; DFLYF:OTCQB) , which specializes in unmanned vehicle technology, announced it was chosen as the exclusive ...
Streetwise Reports | March 27, 2020 |

'Timing is Right' to Invest in Natural Gas Firm Weeks from Production Start

The rationale for this view concerning Alvopetro Energy is explained in a Mackie Research Capital Corp. report. In a June 2 research note, Mackie Research Capital Corp. analyst Bill Newman purported that Alvopetro Energy Ltd. (ALV:TSX.V; ALVOF:OTCQX) currently pr...
Streetwise Reports | June 9, 2020 |

Biopharma's Brain Cancer Therapeutic Compelling, Its Stock Undervalued

A description of the asset and its potential are provided in a Dawson James report. In a July 11 research note, Dawson James Securities analyst Jason Kolbert reported that coverage of DelMar Pharmaceuticals Inc. (DMPI:NASDAQ) transferred to him and, subseq...
Streetwise Reports | July 19, 2019 |

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. In a March 26 research note, analyst Joseph Pantginis reported that IMV Inc.'s (IMV:TSX; IMMVD:OTCQX) preliminary monotherapy data confirmed the efficacy o...
Streetwise Reports | April 1, 2019 |
1 2 3 4 5 6 7 8 9 10 ...